Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950123-20-007914
Filing Date
2020-08-07
Accepted
2020-08-07 18:10:26
Documents
1
Period of Report
2020-08-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4.html 4  
1 PRIMARY DOCUMENT doc4.xml 4 4024
  Complete submission text file 0000950123-20-007914.txt   5333
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Issuer) CIK: 0001492674 (see all company filings)

EIN.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Toft Robin (Reporting) CIK: 0001815565 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36571 | Film No.: 201085767